Medtronic (NYSE:MDT) improved its top and bottom lines in its just-released results for its fiscal Q3 2013. For the quarter, the company posted just over $4 billion in revenue, or a 3% year-over-year improvement from the same period the previous year. Net profit was $988 million ($0.97 per diluted share), which was 6% higher than Q3 2012's $935 million ($0.88).

International sales comprised 46% of the company's total for the quarter, coming in at $1.9 billion. That was a 5% advance over the year-ago Q3.

Looking forward, the company reiterated its previous revenue and EPS guidance. It believes revenue will grow 3%-4% on a year-over-year basis in fiscal 2013, and earnings will amount to $3.66 to $3.70 per share.

Fool contributor Eric Volkman and The Motley Fool own shares of Medtronic. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.